Find a Doctor | Lab & Diagnostics | Pay Now | Get an Opinion
International | Homecare Services | Health Packages
Kailash Hospital - Emergency Center Number EMERGENCY




Dr. Vimal Pandita

Kailash Hospital, Dehradun, Uttarakhand

Designation : Associate Director & Head Medical Oncology

Speciality : Oncology (Cancer)

Areas of Expertise : Chemotherapy, Immunotherapy, Targeted Therapy, Hormonal Therapy, Supportive Care, Bone Marrow

Qualification : MBBS, MD (Medicine), Post Doctorate Certified HBNI fellowship

Book Appointment
Normal OPD
MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY SATURDAY SUNDAY
10:00AM - 4:00PM
Book Now
 10:00AM - 4:00PM
Book Now
 10:00AM - 4:00PM
Book Now
 10:00AM - 4:00PM
Book Now
 10:00AM - 4:00PM
Book Now
 10:00AM - 2:00PM
Book Now
 N/A


Experience

    • Senior Consultant Medical Oncology at Arihant Hospitals Pvt Ltd (March 2021 – January 2024, 2 years 11 months, Dehradun, Uttarakhand, India)
    • Senior Consultant & Incharge Head, Medical Oncology at Max Healthcare (November 2018 – January 2024, 5 years 3 months, Dehradun)
    • Consultant & Incharge, Medical Oncology at Max Healthcare (March 2015 – October 2018, 3 years 8 months, Dehradun)
    • Consultant Medical Oncologist & Hemato Oncologist at Fortis Healthcare (November 2013 – February 2015, 1 year 4 months, Gurgaon - FMRI, Gurugram)

Membership

    • American Society of Clinical Oncology (ASCO)
    • European Society of Medical Oncology (ESMO)
    • Immuno-Oncology Society of India (I-OSI)

Publications

    • Thesis research "Arsenic trioxide versus all trans retinoic acid + chemotherapy in the treatment of newly diagnosed acute promyelocytic leukemia" Published in journal of clinical oncology (JCO) - as abstract in ASCO annual meeting proceedings..
    • Best Poster presentation at Annual Conference of Indian Society of Medical and Paediatric Oncology (ISMPO) Oct. 2009, Srinagar.
    • Pandita, V., Aziz, S.A., Qureshi, T. et al. Metastatic breast cancer to anterior chamber of eye: case report and discussion. Chin. -Ger. J. Clin. Oncol. 10, 491
    • Pandey A, Bhosale B, Pandita V, et al. Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge. Indian J Med Paediatr Oncol. 2014;35(1):17-20. doi:10.4103/0971-5851.133705
    • Bhat GM, Hussain M, Pandita V: Zoledronate induced osteonecrosis of jaw: clinical images-Journal of medical sciences, Vol. 12 No. 1, Jan
    • Ramaswamy A, Ostwal V, Pande N, Sharma A, Patil S, Thippeswamy R, Ghadyalpatil N, Roy R, Peshwe H, Poladia B, Rajamanickam D, Rangarajan B, Neelesh Reddy PR, Pandita V, Mukherjee A, Thoke A, Sarkar A, Satish CT, Shashidara H, Banavali SD. Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study. South Asian J Cancer. 2019 Jan-Mar;8(1):22-26. doi: 10.4103/sajc.sajc_173_18
    • "Proliferative glomerulonephritis with monoclonal Immunoglobulin deposits (PGNMID) associated with underlying haematological malignancy (primary myelofibrosis) with renal extra-medullary haematopoesis" Open journal of Clinical & Medical case reports Arora P; Bansal B; Pandita V

Specializes In

    • Solid Tumor Oncology
    • Immuno Oncology
    • Personalised & Precision Oncology

© 2025 Kailash Healthcare Ltd. All Rights Reserved

Get in Touch

Book Appointment
Get in Touch
Health Packages
Scroll to Top